Category Archives: High-risk pregnancy

Study Finds That Planned C-Sections Provide No Advantage Over Planned Vaginal Birth of Twins

In a study to be presented on February 14 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will report findings that suggest that planned birthing of twins at 32-38 weeks by cesarean section does not decrease perinatal or neonatal death compared to planned vaginal birth.

Society for Maternal Fetal Medicine Recognizes Medical Advancements on World Prematurity Day

Improved screening and effective treatments for prevention of preterm birth are saving infants

In the last five years, multiple medical advancements have led to a decline in the nation’s premature birthrate. On Nov. 17, the Society for Maternal-Fetal Medicine (SMFM) will celebrate World Prematurity Awareness Day to raise global awareness of the problems with premature birth

Study Finds Elevated Levels of Cell-Free DNA in First Trimester Do Not Predict Preeclampsia

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds Elevated Levels of Cell-Free DNA in First Trimester Do Not Predict Preeclampsia

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that  indicate that elevated levels of cell-free DNA in the first trimester do not predict the subsequent development of preeclampsia.

Study Finds Massively Parallel Sequencing Can Detect Fetal Aneuploidies, Including Down Syndrome

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds Massively Parallel Sequencing Can Detect Fetal Aneuploidies, Including Down Syndrome

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that massively parallel sequencing can be used to diagnose fetal aneuploidies, including Down syndrome, Edwards syndrome, Patau syndrome and Turner syndrome.

Study Finds Preterm Labor Diagnostic Markers Not Universal, Diagnosis and Interventions Should Not Be Generalized

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds Preterm Labor Diagnostic Markers Not Universal, Diagnosis and Interventions Should Not Be Generalized

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that preterm birth interventions should be tailored for underlying risk factors and pathways.

Study Finds In Utero Surgery Preferable to Surgery After Birth for Children with Spina Bifida

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds In Utero Surgery Preferable to Surgery After Birth for Children with Spina Bifida

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that show that, for children with spina bifida, surgery conducted while the fetus is still in utero as opposed to surgery on a newborn is more cost effective due to the costs associated with caring for a child with significant deficits.

Study Finds Residence in U.S. a Risk Factor for Preterm Birth

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds Residence in U.S. a Risk Factor for Preterm Birth

 In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that duration of stay in the United States is associated with increased risk of preterm birth for Hispanic women.

Study Finds Some Medications May Interact with Common Anti- Recurrent Preterm Birth Medication

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds Some Medications May Interact with Common Anti- Recurrent Preterm Birth Medication

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that prescription medications may affect the body’s ability to metabolize 17-alpha-hydroxyprogesterone caproate (17-OHPC), the only FDA approved medication for the prevention of recurrent preterm birth.

Study Finds Prior Preterm Delivery Indicates Subsequent Baby Will Be Small Even if Carried to Term

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds Prior Preterm Delivery Indicates Subsequent Baby Will Be Small Even if Carried to Term

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that women who deliver their first baby early are more likely to have a subsequent baby that is small for its gestational age, even when the second pregnancy is carried to term.

2011: Study finds that preterm birth clinic attendance leads to significant reduction in infant disability

In a study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will present findings that show that when women at high risk for preterm birth participated in a preterm birth prevention clinic, more women delivered full term babies and there were fewer cases of infant morbidity.

2011: SMFM highlights significance of spina bifida research findings as reported today in the New England Journal of Medicine

Findings Reviewed at SMFM Annual Meeting, Additional Important Research Presented

More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting ™, represent major findings in reducing high-risk pregnancies and complications.

2011: Study finds that use of 17-Hydroxyprogesterone does not reduce the rate of preterm delivery or neonatal complications in twins

In a study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will present findings that show that the use of the hormone 17-Hydroxyprogesterone does not reduce the rate of preterm delivery or neonatal complications in twins.

2011 March of Dimes Award Abstract: New research helps explain how progesterone prevents preterm birth

Research presented today at the 31st Annual meeting of the Society for Maternal-Fetal Medicine (SMFM) ― The Pregnancy Meeting™ has found that three proteins known as XIAP, BID, and Bcl-2 are responsible in part for the success of progesterone treatments in the prevention of preterm labor. They may also play an important role in triggering normal labor.

2010: Maternal-fetal medicine subspecialty expands due to increasingly complicated pregnancies, emerging technologies and rises in preterm birth

SMFM Report Highlights Growing Need for Specialists

The rate of preterm birth (before 37 weeks) in the United States has steadily increased over the last two decades; reaching one in eight babies (12.7%) in 2007. There are over 500,000 preterm births each year in the U.S. Another frightening statistic is that stillbirths account for 58% of all perinatal deaths before 28 days of life and 48% of all deaths in the first year of life.

Powered by WordPress | Designed by: seo service | Thanks to seo company, web designers and internet marketing company